The BIPAVE-001 Phase 1/2 trial is designed to evaluate the safety, pharmacokinetic, and efficacy of AI-081 in two integrated parts. Part A is an ongoing, first-in-human Phase 1 dose escalation and ...

OncoC4 Doses First Patient with Potential Best-in-Class PD-1/VEGF Bispecific Antibody AI-081 in Phase 2 Portion of BIPAVE-001 Trial for Advanced Solid Tumors in US ...

This manuscript presents an in-depth analysis of gene expression across multiple brown algal species with differing life histories, providing convincing evidence for the conservation of life ...

A 2-year-old girl nearly drowned in Washington Township on Tuesday, July 22, authorities said. At 6:13 p.m., officers responded to a residence on Spring Lake Avenue for a report of a possible ...